BeStock  
Stocks › Biotechnology › AKTS

Aktis Oncology AKTS

US equityMarket cap rank #3242Biotechnology
$18.00 +$0.14 (+0.78%)
Pre-market · Oct 8, 8:50 am ET · After hours $18.00 0.00%
Open$17.72
Prev close$17.86
Day range$17.70 – $18.35
Volume294.1K
Market cap$1.00B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$35.80+98.9% vs. price
  • Buy 100%
Low $33.00Now $18.00Avg $35.80High $40.00

Recent rating changes

The last 20 actions on file set price targets from $33.00 to $40.00, averaging $35.81.

DateFirmRatingTarget
2 Oct 2026 Wedbush BUY $35.00
9 Sep 2026 Oppenheimer BUY $40.00
19 Aug 2026 Wedbush BUY $35.00
18 Aug 2026 BMO Capital BUY $37.00
14 Aug 2026 William Blair BUY –
14 Aug 2026 BofA Securities BUY $34.00
14 Aug 2026 J.P. Morgan BUY $33.00
14 Jul 2026 William Blair BUY –
14 Jul 2026 J.P. Morgan BUY $33.00
16 Jun 2026 Raymond James BUY $40.00
15 Jun 2026 Raymond James BUY $40.00
12 Jun 2026 Raymond James BUY $40.00
3 Jun 2026 H.C. Wainwright BUY $35.00
2 Jun 2026 H.C. Wainwright BUY $35.00
1 Jun 2026 William Blair BUY –
31 May 2026 BofA Securities BUY $34.00
27 May 2026 William Blair BUY –
27 May 2026 BofA Securities BUY $34.00
22 May 2026 BofA Securities BUY $34.00
15 May 2026 BofA Securities BUY $34.00

Discussion

No comments yet — be the first to weigh in on AKTS.

Leave a comment

Scroll to Top